Jundishapur Journal of Microbiology

Published by: Kowsar

Assessment of the Human Cytomegalovirus UL97 Gene for Identification of Resistance to Ganciclovir in Iranian Immunosuppressed Patients

Hossein Keyvani 1 , 2 , Sedigheh Taghinezhad Saroukalaei 2 , 3 and Amir Hossein Mohseni 2 , 3 , *
Authors Information
1 School of Medicine, Iran University of Medical Sciences, Tehran, IR Iran
2 Research and Development Department, Keyvan Virology Specialty Laboratory (KVSL), Tehran, IR Iran
3 Department of Microbiology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: May 01, 2016, 9 (5); e31733
  • Published Online: May 29, 2016
  • Article Type: Research Article
  • Received: July 22, 2015
  • Revised: April 12, 2016
  • Accepted: April 23, 2016
  • DOI: 10.5812/jjm.31733

To Cite: Keyvani H, Taghinezhad Saroukalaei S, Mohseni A H. Assessment of the Human Cytomegalovirus UL97 Gene for Identification of Resistance to Ganciclovir in Iranian Immunosuppressed Patients, Jundishapur J Microbiol. 2016 ; 9(5):e31733. doi: 10.5812/jjm.31733.

Abstract
Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS): clinical findings, diagnosis, and treatment. Ann Intern Med. 1988; 108(4): 585-94[PubMed]
  • 2. Miller W, Flynn P, McCullough J, Balfour HJ, Goldman A, Haake R, et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood. 1986; 67(4): 1162-7[PubMed]
  • 3. Numata S, Nakamura Y, Imamura Y, Honda J, Momosaki S, Kojiro M. Rapid quantitative analysis of human cytomegalovirus DNA by the real-time polymerase chain reaction method. Arch Pathol Lab Med. 2005; 129(2): 200-4[DOI][PubMed]
  • 4. Boriskin YS, Fuller K, Powles RL, Vipond IB, Rice PS, Booth JC, et al. Early detection of cytomegalovirus (CMV) infection in bone marrow transplant patients by reverse transcription-PCR for CMV spliced late gene UL21. 5: a two site evaluation. J Clin Virol. 2002; 24(1-2): 13-23[PubMed]
  • 5. Yun Z, Lewensohn-Fuchs I, Ljungman P, Vahlne A. Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays. Transplantation. 2000; 69(8): 1733-6[PubMed]
  • 6. Sanchez JL, Storch GA. Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol. 2002; 40(7): 2381-6[PubMed]
  • 7. Balfour HJ. Management of cytomegalovirus disease with antiviral drugs. Rev Infect Dis. 1990; 12 Suppl 7-60[PubMed]
  • 8. Lalezari JP, Drew WL, Glutzer E, James C, Miner D, Flaherty J, et al. (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J Infect Dis. 1995; 171(4): 788-96[PubMed]
  • 9. Lalezari JP, Stagg RJ, Kuppermann BD, Holland GN, Kramer F, Ives DV, et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med. 1997; 126(4): 257-63[PubMed]
  • 10. Reid R, Mar EC, Huang ES, Topal MD. Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate. J Biol Chem. 1988; 263(8): 3898-904[PubMed]
  • 11. Hantz S, Garnier-Geoffroy F, Mazeron MC, Garrigue I, Merville P, Mengelle C, et al. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study. J Antimicrob Chemother. 2010; 65(12): 2628-40[DOI][PubMed]
  • 12. Hantz S, Michel D, Fillet AM, Guigonis V, Champier G, Mazeron MC, et al. Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient. Antimicrob Agents Chemother. 2005; 49(4): 1580-3[DOI][PubMed]
  • 13. Baldanti F, Silini E, Sarasini A, Talarico CL, Stanat SC, Biron KK, et al. A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol. 1995; 69(2): 796-800[PubMed]
  • 14. Baldanti F, Michel D, Simoncini L, Heuschmid M, Zimmermann A, Minisini R, et al. Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system. Antiviral Res. 2002; 54(1): 59-67[PubMed]
  • 15. Baldanti F, Lurain N, Gerna G. Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. Hum Immunol. 2004; 65(5): 403-9[DOI][PubMed]
  • 16. Chou S, Waldemer RH, Senters AE, Michels KS, Kemble GW, Miner RC, et al. Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir. J Infect Dis. 2002; 185(2): 162-9[DOI][PubMed]
  • 17. Chou S, Meichsner CL. A nine-codon deletion mutation in the cytomegalovirus UL97 phosphotransferase gene confers resistance to ganciclovir. Antimicrob Agents Chemother. 2000; 44(1): 183-5[PubMed]
  • 18. Alain S, Honderlick P, Grenet D, Stern M, Vadam C, Sanson-Le Pors MJ, et al. Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient. Transplantation. 1997; 63(10): 1533-6[PubMed]
  • 19. Chou S, Marousek G, Parenti DM, Gordon SM, LaVoy AG, Ross JG, et al. Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy. J Infect Dis. 1998; 178(2): 526-30[PubMed]
  • 20. Hanson MN, Preheim LC, Chou S, Talarico CL, Biron KK, Erice A. Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrob Agents Chemother. 1995; 39(5): 1204-5[PubMed]
  • 21. Wolf DG, Yaniv I, Honigman A, Kassis I, Schonfeld T, Ashkenazi S. Early emergence of ganciclovir-resistant human cytomegalovirus strains in children with primary combined immunodeficiency. J Infect Dis. 1998; 178(2): 535-8[PubMed]
  • 22. Wolf DG, Smith IL, Lee DJ, Freeman WR, Flores-Aguilar M, Spector SA. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J Clin Invest. 1995; 95(1): 257-63[DOI][PubMed]
  • 23. Wolf DG, Lee DJ, Spector SA. Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease. Antimicrob Agents Chemother. 1995; 39(11): 2552-4[PubMed]
  • 24. Sullivan V, Biron KK, Talarico C, Stanat SC, Davis M, Pozzi LM, et al. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Antimicrob Agents Chemother. 1993; 37(1): 19-25[PubMed]
  • 25. Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature. 1992; 358(6382): 162-4[DOI][PubMed]
  • 26. Smith IL, Cherrington JM, Jiles RE, Fuller MD, Freeman WR, Spector SA. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J Infect Dis. 1997; 176(1): 69-77[PubMed]
  • 27. Prix L, Maierl J, Jahn G, Hamprecht K. A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains. J Clin Virol. 1998; 11(1): 29-37[PubMed]
  • 28. Pepin JM, Simon F, Dussault A, Collin G, Dazza MC, Brun-Vezinet F. Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures. J Clin Microbiol. 1992; 30(11): 2917-20[PubMed]
  • 29. Gerna G, Sarasini A, Percivalle E, Zavattoni M, Baldanti F, Revello MG. Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples. J Clin Microbiol. 1995; 33(3): 738-41[PubMed]
  • 30. Landry ML, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, et al. A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates. Antimicrob Agents Chemother. 2000; 44(3): 688-92[PubMed]
  • 31. Liu JB, Zhang Z. Development of SYBR Green I-based real-time PCR assay for detection of drug resistance mutations in cytomegalovirus. J Virol Methods. 2008; 149(1): 129-35[DOI][PubMed]
  • 32. Chakravarti A, Kashyap B, Matlani M. Cytomegalovirus infection: an Indian perspective. Indian J Med Microbiol. 2009; 27(1): 3-11[PubMed]
  • 33. Khansarinejad B, Soleimanjahi H, Mirab Samiee S, Hamidieh AA, Paryan M, Sanahmadi Y. Quantitation of human cytomegalovirus DNA in plasma using an affordable in-house qPCR assay. J Virol Methods. 2012; 183(2): 170-5[DOI][PubMed]
  • 34. Kanaan A, Cour I, Alvarez-Lafuente R, Benedicto M, Culebras E, Prats D, et al. Significance of nested PCR and quantitative real time PCR for cytomegalovirus detection in renal transplant recipients. Int J Antimicrob Agents. 2004; 24(5): 455-62[DOI][PubMed]
  • 35. Benzi F, Vanni I, Cassina G, Ugolotti E, Di Marco E, Cirillo C, et al. Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients. J Clin Virol. 2012; 54(1): 48-55[DOI][PubMed]
  • 36. Lurain NS, Chou S. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev. 2010; 23(4): 689-712[DOI][PubMed]
  • 37. Gilbert C, Boivin G. Human cytomegalovirus resistance to antiviral drugs. Antimicrob Agents Chemother. 2005; 49(3): 873-83[DOI][PubMed]
  • 38. Baldanti F, Gerna G. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact. J Antimicrob Chemother. 2003; 52(3): 324-30[DOI][PubMed]
  • 39. Erice A. Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev. 1999; 12(2): 286-97[PubMed]
  • 40. Marfori JE, Exner MM, Marousek GI, Chou S, Drew WL. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients. J Clin Virol. 2007; 38(2): 120-5[DOI][PubMed]
  • 41. Gentry BG, Vollmer LE, Hall ED, Borysko KZ, Zemlicka J, Kamil JP, et al. Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97. Antimicrob Agents Chemother. 2013; 57(9): 4343-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments